Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

Obesity Clinical Trial

— CLOVER  

Official title:

Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04540081
• Other study ID #: 1624888
• Status: Completed
• Phase: N/A
• Start date: October 5, 2020
• Est. completion date: October 5, 2022

Study information

• Verified date: November 2021
• Source: University of California, Davis
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of CLOVER is to utilize Epic Healthy Planet to increase adherence to United States Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommendations in adults age 50 and older.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20000
• Est. completion date: October 5, 2022
• Est. primary completion date: October 5, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years to 80 Years

Eligibility

Inclusion Criteria:

• Any patient who has a UC Davis or UC Irvine primary care provider (PCP) and is deficient in any of the following: colon cancer screening, lung cancer screening, tobacco cessation counseling, obesity counseling, pneumonia vaccination, shingles vaccine, and hepatitis C screening.

Exclusion Criteria:

• Patients outside of the age limits or have an established PCP.

Related Conditions & MeSH terms

• Colon Cancer
• Colonic Neoplasms
• Hepatitis C
• Liver Neoplasms
• Lung Cancer
• Lung Neoplasms
• Obesity
• Pneumonia, Bacterial
• Shingles
• Tobacco Use Cessation

Intervention

Other:
• Epic Healthy Planet Population Health Module
Electronic population health module which is tailored to increased adherence to USPSTF and CDC recommendations

Locations

Country	Name	City	State
United States	UC Davis Medical Center	Sacramento	California

Sponsors (2)

Lead Sponsor	Collaborator
University of California, Davis	University of California, Irvine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Overall Adherence to CLOVER Metrics	This is the proportion of patients who appropriately completed screenings and vaccinations that they were eligible for	6 months
Secondary	Colon cancer screening	Proportion of eligible patients who completed colon cancer screening.	6 months
Secondary	Lung cancer screening	Proportion of eligible patients who completed lung cancer screening.	6 months
Secondary	Tobacco cessation counseling	Proportion of eligible patients who completed tobacco cessation counseling.	6 months
Secondary	Obesity counseling	Proportion of eligible patients who completed obesity counseling.	6 months
Secondary	Pneumonia vaccination	Proportion of eligible patients who completed pneumonia vaccination.	6 months
Secondary	Shingles vaccination	Proportion of eligible patients who completed shingles vaccination.	6 months
Secondary	Hepatitis C screening	Proportion of eligible patients who completed hepatitis C screening.	6 months